In our study, the similar correlation patterns of GIP or GLP-1 with metabolic and hormonal markers suggest coordinated roles in PCOS pathophysiology and reinforce the potential of dual-agonist therapy. The gene discussed is GCG; the disease is polycystic ovary syndrome.